Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · Real-Time Price · USD
11.45
+0.70 (6.52%)
Nov 21, 2024, 1:54 PM EST - Market open
Avadel Pharmaceuticals Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for AVDL stock have an average target of 24, with a low estimate of 21 and a high estimate of 30. The average target predicts an increase of 109.61% from the current stock price of 11.45.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AVDL stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $27 → $25 | Strong Buy | Maintains | $27 → $25 | +118.34% | Nov 13, 2024 |
| Needham | Needham | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +92.14% | Nov 13, 2024 |
| Needham | Needham | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +92.14% | Nov 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $27 | Strong Buy | Reiterates | $27 | +135.81% | Oct 31, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $29 → $30 | Buy | Maintains | $29 → $30 | +162.01% | Oct 31, 2024 |
Financial Forecast
Revenue This Year
177.07M
from 27.96M
Increased by 533.23%
Revenue Next Year
306.48M
from 177.07M
Increased by 73.08%
EPS This Year
-0.47
from -2.00
EPS Next Year
0.70
from -0.47
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 189.2M | 350.2M | 469.0M | ||
| Avg | 177.1M | 306.5M | 408.8M | ||
| Low | 165.0M | 274.4M | 337.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 576.5% | 97.8% | 53.0% | ||
| Avg | 533.2% | 73.1% | 33.4% | ||
| Low | 490.0% | 55.0% | 10.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.07 | 1.72 | 3.26 | ||
| Avg | -0.47 | 0.70 | 1.67 | ||
| Low | -0.58 | 0.25 | 0.72 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 368.0% | ||
| Avg | - | - | 140.5% | ||
| Low | - | - | 2.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.